Trial intelligence / Profile preview

Lithium plus Fluoxetine for Prevention of Bipolar Depression Relapse

NCT00961961Phase 4Completed

Sponsor
University of Pennsylvania
Start
Jul 2009
Primary completion
Sep 2016
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of fluoxetine in bipolar I disorder (3 arms), sponsored by University of Pennsylvania. Primary endpoint: Number of Participants With Relapse of Major Depressive Episode Within 1 Year. Started Jul 2009; status: completed.

02

Drugs

fluoxetine
03

Conditions

bipolar I disorder

Beyond the preview

Go deeper on NCT00961961.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00961961.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call